Home >  Gastroenterology MDTV >  Gastroenterology Shorts MDTV >  Study finds personalized...

Study finds personalized antibiotics, prebiotics, and probiotics combo may help treat IBS

By - Anshika Mishra
Published On 2024-05-07 03:00 GMT   |   Update On 2024-05-07 03:00 GMT
Advertisement

A study presented at the European Society of Clinical Microbiology and Infectious Diseases conference revealed that over a third of patients treated with a precision approach to post-infectious irritable bowel syndrome (IBS) reported improved symptoms 12 weeks after starting treatment.

IBS is a chronic condition that affects a person’s digestive system. Symptoms include recurrent pain and changes to bowel habits.
Irritable bowel syndrome (IBS) is a common gastrointestinal disorder characterized by symptoms such as abdominal pain, bloating, gas, diarrhea, and constipation. It is a chronic condition that affects the large intestine and can significantly impact a person's quality of life. While the exact cause of IBS is not fully understood, it is believed to involve a combination of factors including abnormal gastrointestinal motility, increased sensitivity to certain foods, stress, and alterations in the gut microbiota.
Advertisement
In the study, researchers recruited 13 participants and prescribed a specific regime of one of two antibiotics to treat pathogenic bacteria that existed at levels that were too high, as well as probiotics to replace beneficial strains that were at levels that were too low. Prebiotics including inulin and psyllium were prescribed to over two-thirds of participants.
After 12 weeks of treatment initiation, 12 out of 13 participants showed symptom improvement. Initially reported symptoms included abdominal pain, bloating, diarrhea, constipation, weight loss, and dyspepsia. Following treatment, the predominant symptoms were abdominal pain, bloating, and diarrhea. Additionally, five participants achieved complete symptom remission.
“As there is significant variation between even healthy individuals’ microbiome, it was unclear whether the dysbiosis — the imbalance between different bacterial strains in the gut — that occurs in people with post-infectious IBS had caused the symptoms they experienced. People should have their microbiomes sequenced when they are healthy for research in this area to advance, and causal factors to be identified. If we can get to that stage, I think we will truly practice personalized medicine, and we can get much better in targeting treatments with some of these antibiotics, probiotics, or prebiotics,” explained Satish Rao, gastroenterologist and professor of medicine at the Medical College of Georgia, Augusta University.
Reference: European Society of Clinical Microbiology and Infectious Diseases conference: Barcelona, Spain- 27-30 April; Can a personalized antibiotics, prebiotics, and probiotics combo help treat IBS?
Full View
Tags:    

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Anshika Mishra

Anshika Mishra is a dedicated scholar pursuing a Masters in Biotechnology, driven by a profound passion for exploring the intersection of science and healthcare. Having embarked on this academic journey with a passion to make meaningful contributions to the medical field, Anshika joined Medical Dialogues in 2023 to further delve into the realms of healthcare journalism.

Comments Policy
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News

Study Finds Yogurt and Hot Spring Baths Boost Gut Health Together

Lancet Commission Urges Global Action to Curb Rising Liver Cancer Burden by 2050

Common Non-Antibiotic Drugs May Harm Gut Microbiome and Raise Infection Risk: Study Shows

Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Rectal Cancer - Dr. Poulami Basu

These Diets May Help Prevent Chronic Constipation: Study Shows

Caltech Engineers Develop Smart Ingestible Capsule for Real-Time Gut Health Monitoring

New Blood Test May Detect Early Liver Transplant Rejection: Study Suggests

Six in Ten with Type 2 Diabetes Have Fatty Liver: Study Finds